Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)
Centro singular
![Foto de Centro de Investigación en Medicina Molecular e Enfermidades Crónicas (CIMUS)](/img/noimage.png)
![Foto de Medical University of South Carolina](/img/noimage_org.png)
Medical University of South Carolina
Charleston, Estados UnidosPublicacións en colaboración con investigadores/as de Medical University of South Carolina (8)
2022
-
Methionine adenosyltransferase 1a antisense oligonucleotides activate the liver-brown adipose tissue axis preventing obesity and associated hepatosteatosis
Nature Communications, Vol. 13, Núm. 1
2020
-
Liver osteopontin is required to prevent the progression of age-related nonalcoholic fatty liver disease
Aging Cell, Vol. 19, Núm. 8
2011
-
Diagnostic Value of N-Terminal Pro-Brain Natriuretic Peptide in Pleural Effusions of Cardiac Origin
Archivos de Bronconeumologia, Vol. 47, Núm. 5, pp. 246-251
1999
-
Quantification of N-(glucitol)ethanolamine and N-(carboxymethyl)serine: Two products of nonenzymatic modification of aminophospholipids formed in vivo
Analytical Biochemistry, Vol. 272, Núm. 1, pp. 48-55
1997
-
Carboxymethylethanolamine, a biomarker of phospholipid modification during the Maillard reaction in vivo
Journal of Biological Chemistry, Vol. 272, Núm. 28, pp. 17473-17479
-
Quantification of malondialdehyde and 4-hydroxynonenal adducts to lysine residues in native and oxidized human low-density lipoprotein
Biochemical Journal, Vol. 322, Núm. 1, pp. 317-325
1996
-
Lipoxidation products as biomarkers of oxidative damage to proteins during lipid peroxidation reactions
Nephrology Dialysis Transplantation
-
The advanced glycation end product, N∈-(carboxymethyl)lysine, is a product of both lipid peroxidation and glycoxidation reactions
Journal of Biological Chemistry, Vol. 271, Núm. 17, pp. 9982-9986